AI MARKET SCANNING

Korro Bio Inc

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -6.48%
MAX GAP RECORD -77.75%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $KRRO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-2.55%
Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE)
+19.91%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
-77.75%
Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN)
-3.79%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-1.79%
Mar 18, 2025 Earnings Release 2025-03-18 (BEFORE OPEN)
-0.56%

VOLATILITY & GAP BIAS

AVG GAP MOVE 11.7%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $KRRO

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge,…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗